Provided by Tiger Trade Technology Pte. Ltd.

Rhythm Pharmaceuticals Inc.

99.15
+0.50000.51%
Pre-market: 102.503.35+3.38%08:00 EST
Volume:616.63K
Turnover:61.10M
Market Cap:6.62B
PE:-31.92
High:101.96
Open:99.05
Low:97.71
Close:98.65
52wk High:122.20
52wk Low:45.91
Shares:66.74M
Float Shares:53.42M
Volume Ratio:0.91
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1057
EPS(LYR):-4.3376
ROE:-85.79%
ROA:-26.74%
PB:44.46
PE(LYR):-22.86

Loading ...

Rhythm Pharmaceuticals (RYTM): Assessing Valuation as Citigroup Sparks Fresh Optimism with New 'Buy' Rating

Simply Wall St.
·
Nov 29, 2025

How Positive Analyst Coverage at Rhythm Pharmaceuticals (RYTM) Has Changed Its Investment Story

Simply Wall St.
·
Nov 27, 2025

Rhythm Pharmaceuticals Initiated at Buy by Citigroup

Dow Jones
·
Nov 25, 2025

Citigroup Initiates Rhythm Pharmaceuticals at Buy With $136 Price Target

MT Newswires Live
·
Nov 25, 2025

Rhythm Pharmaceuticals initiated with a Buy at Citi

TIPRANKS
·
Nov 25, 2025

Rhythm Pharmaceuticals Chief Human Resources Officer Pamela J. Cramer Reports Disposal of Common Shares

Reuters
·
Nov 25, 2025

S&P 500 Futures Climb In Premarket Trading; Centene, Millicom Intl Cellular Lead

Dow Jones
·
Nov 24, 2025

Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE (setmelanotide) for Patients with Acquired Hypothalamic Obesity

Reuters
·
Nov 20, 2025

FDA Review Extension for IMCIVREE Might Change the Case for Investing in Rhythm Pharmaceuticals (RYTM)

Simply Wall St.
·
Nov 17, 2025

S&P 500 Futures Up In Premarket Trading; Jazz Pharmaceuticals, Clearwater Analytics Lead

Dow Jones
·
Nov 17, 2025

Rhythm Pharmaceuticals Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Nov 11, 2025

Rhythm Pharmaceuticals Reports Setmelanotide Significantly Reduces BMI in Hypothalamic Obesity Phase 3 Trial

Reuters
·
Nov 10, 2025

Rhythm Pharmaceuticals price target raised to $114 from $105 at Canaccord

TIPRANKS
·
Nov 10, 2025

Analysts’ Top Healthcare Picks: Rhythm Pharmaceuticals (RYTM), Eli Lilly & Co (LLY)

TIPRANKS
·
Nov 10, 2025

Rhythm Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Nov 08, 2025

Sector Update: Health Care Stocks Retreat Friday Afternoon

MT Newswires Live
·
Nov 08, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive

Reuters
·
Nov 08, 2025

BUZZ-U.S. STOCKS ON THE MOVE-ANI Pharmaceuticals, Wendy's, nLIGHT

Reuters
·
Nov 07, 2025

BUZZ-Rhythm falls after US FDA delays decision on drug for brain damage-related obesity

Reuters
·
Nov 07, 2025

Rhythm Pharmaceuticals Shares Down 3.5% Premarket After US FDA Extends Review of Co's Brain Damage-Related Obesity Drug

THOMSON REUTERS
·
Nov 07, 2025